ADDITIONAL RESOURCES
Source: http://en.wikipedia.org/wiki/Salvia_divinorum
- Baca, Rep. Joe (Oct 2002). "To amend the Controlled Substances Act to place Salvinorin A in Schedule I (H.R.5607)". Bills, Resolutions. The Library of Congress (THOMAS). Retrieved on 2007-10-14.
- Baggott, Matthew & Erowid, E. & F. (June 2004), "A Survey of Salvia divinorum Users", Erowid Extracts 6: 12–14, <http://www.erowid.org/general/newsletter/erowid_newsletter6.pdf>. Retrieved on 4 May 2007
- Bigham, Andrea K.; Munro, Thomas A.; Rizzacasa, Mark A. & Robins-Browne, Roy M. (July 2003), "Divinatorins A-C, New Neoclerodane Diterpenoids from the Controlled Sage Salvia divinorum.", Journal of Natural Products 66(9): 1242–1244, doi:10.1021/np030313i, <http://www.sagewisdom.org/divinatorinsa-c.pdf>. Retrieved on 25 June 2007
- Blosser, Brett. "Lessons in The Use of Mazatec Psychoactive Plants". The Salvia divinorum Research and Information Center. Retrieved on 2007-10-19.
- Boire, Richard Glen; Russo, Ethan & Fish, Adam Richard et al. (Oct 2002). "Salvia divinorum ~ Information Concerning the Plant and its Active Principle—(re. H.R. 5607)". The Salvia divinorum Defense Fund. Center for Cognitive Liberty & Ethics (CCLE). Retrieved on 2007-10-16.
- Burchett, Sen. Tim (2006). "Senate Bill No. 3247". Public Acts, 2006, Chapter No. 700. The General Assembly the State of Tennessee. Retrieved on 2007-10-16.
- Carlezon, William A.; Béguin, Cécile & DiNieri, Jennifer A. (October 2005), "Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats", Journal of Pharmacology And Experimental Therapeutics 316(1): 440–447, doi:10.1124/jpet.105.092304, PMID 16223871, <http://jpet.aspetjournals.org/cgi/content/abstract/316/1/440>. Retrieved on 4 May 2007
- CCLE (2002). "HR 5607 Archive". The Entheogens and Drug Policy Project. Center for Cognitive Liberty & Ethics. Retrieved on 2007-10-14.
- DEA (US Dept. Justice) (Jan 2002). "21 USC Sec. 812 01/22/02". Controlled Substances Act—Title 21—Food and Drugs Chapter 13—Drug Abuse Prevention and Control Subchapter I—Control and Enforcement Part B—Authority To Control; Standards and Schedules—Section 812. Schedules of controlled substances. U.S. Drug Enforcement Administration (DEA). Retrieved on 2007-10-06.
- DEA (US Dept. Justice) (Jun 2003). "Information Bulletin: Salvia Divinorum". Microgram Bulletin XXXVI (6). Office of Forensic Sciences Washington, D.C.: U.S. Drug Enforcement Administration (DEA). Retrieved on 2007-10-14.
- DEA (US Dept. Justice) (Jun 2008). "Salvia Divinorum and Salvinorin A". Drugs and Chemicals of Concern. Office of Diversion Control—U.S. Drug Enforcement Administration (DEA). Retrieved on 2008-09-15.
- Dweck, Anthony C. (1997) Chapter One: The Folklore and Cosmetic Use of Various Salvia Species. Retrieved July 21, 2007.
- Erowid. "Salvia Legal Status". Erowid. Retrieved on 2007-10-14.
- Erowid (August 2007). "Cacahuaxochitl". Retrieved on 2007-08-16.
- Hanes, Karl R. (December 2001), "Antidepressant Effects of the Herb Salvia Divinorum: A Case Report", Journal of Clinical Psychopharmacology 21(6): 634–635, doi:10.1097/00004714-200112000-00025, <http://www.sagewisdom.org/jclinpsych.html>. Retrieved on 8 May 2007
- Harding, Wayne W.; Schmidt, Matthew & Tidgewell, Kevin (January 2006), "Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Semisynthesis of Salvinicins A and B and Other Chemical Transformations of Salvinorin A", Journal of Natural Products 69(1): 107–112, doi:10.1021/np050398i, PMID 16441078, <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16441078&query_hl=15&itool=pubmed_docsum>. Retrieved on 24 March 2007
- Hingson, Ralph; Timothy Heeren, Michael Winter & Henry Wechsler (Apr 2005). "Magnitude of Alcohol-Related Mortality and Morbidity Among U.S. College Students Ages 18-24: Changes from 1998 to 2001". Annual Review of Public Health 26: 259–279. doi:10.1146/annurev.publhealth.26.021304.144652. PMID 15760289. figures cited by the Marin Institute
- Imanshahidi, Mohsen & Hosseinzadeh, Hossein (April 2006), "The Pharmacological Effects of Salvia species on the Central Nervous System", Phytotherapy Research 20: 427–437, doi:10.1002/ptr.1898, <http://www3.interscience.wiley.com/cgi-bin/abstract/112593742/ABSTRACT>. Retrieved on 24 March 2007
- Lizard (2001). "Green Gnosis (from Salvia Divinorum Inspired Arts)". The Salvia divinorum Research and Information Center. Retrieved on 2007-06-28.
- Lopez, Alan D (Apr 2005). "The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action". Globalization and Health 1 (5): 5. BioMed Central Ltd. doi:10.1186/1744-8603-1-5. PMID 15847690. Table 2. Global burden of disease and injury attributable to selected risk factors, 1990.
- Madison, James et al. The Bill of Rights, the First Amendment (with regard to the United States Constitution), approved September 25, 1789, ratified December 15, 1791.
- Mann, John (MP) (Oct 2005). "EDM 796—Salvia divinorum". Early Day Motion. Parliamentary Information Management Systems (pims). Retrieved on 2007-10-14.
- Marushia, Robin (June 2003), "Salvia divinorum: The Botany, Ethnobotany, Biochemistry and Future of a Mexican Mint", Ethnobotany, <http://216.239.59.104/search?q=cache:2DxTYfAd0UAJ:maya.ucr.edu/pril/ethnobotany/image/Salvia.pdf>. Retrieved on 4 May 2007
- Medana, Claudio; Massolino, Cristina; Pazzi, Marco & Baiocchi, Claudio (December 2005), "Determination of salvinorins and divinatorins in Salvia divinorum leaves by liquid chromatography/multistage mass spectrometry", Rapid Communications in Mass Spectrometry 20(2): 131–136, doi:10.1002/rcm.2288, <http://www3.interscience.wiley.com/cgi-bin/abstract/112163281/ABSTRACT>. Retrieved on 4 May 2007
- Mercury House Publishing Home Page. Mercury House Authors: Dale Pendell. Retrieved July 21, 2007.
- Munro, Thomas A. & Rizzacasa, Mark A. (April 2003), "Salvinorins D-F, New Neoclerodane Diterpenoids from Salvia divinorum, and an Improved Method for the Isolation of Salvinorin A", Journal of Natural Products 66(5): 703–705, doi:10.1021/np0205699, <http://www.sagewisdom.org/salvinorind-f.pdf>. Retrieved on 25 June 2007 supporting information
- Mowry, Mark; Mosher, Michael & Briner, Wayne (July 2003), "Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A", Journal of Psychoactive Drugs 35(3): 379–382, PMID 14621136, <http://www.sagewisdom.org/mowryetal.pdf>. Retrieved on 4 May 2007
- Nance, Rep. John (2006). "House Bill No. 2485". 2nd Session of the 50th Legislature. The State of Oklahoma. Retrieved on 2007-10-16.
- NIAAA (Aug 2001). "Number of deaths and age-adjusted death rates per 100,000 population for categories of alcohol-related (A-R) mortality, United States and States, 1979-96.". Database Resources / Statistical Tables. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Retrieved on 2007-10-20.
- Nutt, David; King, Leslie; Saulsbury, William & Blakemore, Colin (March 2007), "Development of a rational scale to assess the harm of drugs of potential misuse", The Lancet 369(9566): 1047–1053, doi:10.1016/S0140-6736(07)60464-4, <http://www.thelancet.com/journals/lancet/article/PIIS0140673607604644/abstract>. Retrieved on 23 March 2007
- Ott, Jonathan (1995). "Ethnopharmacognosy and Human Pharmacology of Salvia divinorum and Salvinorin A". Curare 18 (1): 103–129. Retrieved on 2007-08-16.
- Pendell, Dale (1995). "The Salvia divinorum chapter", Pharmako/Poeia: Plant Powers, Poisons, and Herbcraft. San Francisco: Mercury House. ISBN 1-56279-069-2. Retrieved on 2007-06-28.
- Peterson, Sen. Karen (2006). "Chapter 256—Formerly Senate Bill No 259 (aka “Brett’s Law”)". An Act to Amend Title 16 of the Delaware Code Relating to the Uniform Controlled Substances Act. The General Assembly of the State of Delaware. Retrieved on 2007-10-16.
- Prisinzano, Thomas E. (2005), "Psychopharmacology of the hallucinogenic sage Salvia divinorum", Life Sciences 78: 527–531. Retrieved on 21 December 2006
- Reboletti, Rep. Dennis (Jan 2007). "Full Text of HB0457". Cont Sub-Salvia divinorum. Illinois General Assembly. Retrieved on 2007-10-16.
- Reboletti, Dennis (Mar 2007). "Reboletti Passes First Bill, Bans “Magic Mint”". Illinois State Representative Dennis M. Reboletti (R) 46th District. Archived from the original on 2007-06-08. Retrieved on 2007-06-08.
- Reisfield, Aaron S. (1993), "The botany of Salvia divinorum (Labiatae)", SIDA, Contributions to Botany 15(3): 349–366, <http://www.sagewisdom.org/reisfield.html>. Retrieved on 4 May 2007
- Roth, Bryan L.; Baner, Karen; Westkaemper, Richard; Siebert, Daniel; Rice, Kenner C.; Steinberg, SeAnna; Ernsberger, Paul & Rothman, Richard B. (September 2002), "Salvinorin A: A potent naturally occurring nonnitrogenous kappa к opioid selective agonist", PNAS 99(18): 11934–11939, doi:10.1073/pnas.182234399, PMID 12192085, <http://www.pnas.org/cgi/content/full/99/18/11934>. Retrieved on 24 March 2007- supporting info table 1, table 2, table 3.
- Roth, Bryan L. (Jul 2007). "Fast Moving Fronts—Comments by Professor Bryan Roth". Essential Science Indicators (ESI). Retrieved on 2007-10-06.
- Rothman, RB; DA Gorelick & SJ Heishman et al. (April 2000). "An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence". Journal of Substance Abuse Treatment 18 (3): 277–281. doi:10.1016/S0740-5472(99)00074-4.
- Sak, Rep. Michael (Feb 2008). "House Bill 5700". Michigan Legislature. Retrieved on 2007-10-16. - Full Text of HB5700
- SAMHSA (Feb 2008). "The NSDUH Report: Use of Specific Hallucinogens: 2006". Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Retrieved on 2008-05-09.
- Schenk, S. & Partridge, B. (April 2001), "Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behavior.", Pharmacol Biochem Behav. 68(4): 629–34, doi:10.1016/S0091-3057(00)00478-0, PMID 11526958, <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11526958&dopt=abstract>. Retrieved on 20 May 2007
- Schultes, Richard Evans; Albert Hofmann (1992). Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers. Rochester, Vermont: Healing Arts Press. ISBN 0-89281-406-3. Retrieved on 2007-06-27.
- Shulgin, Dr. Alexander; Ann Shulgin (1997). "LSD-25", PiHKAL. Berkeley: Transform Press. ISBN 0-963-00969-9. Retrieved on 2008-09-12.
- Shulgin, Dr. Alexander (Jun 2003). "Ask Dr. Shulgin Online". Salvia Divinorum, Law, & Medicine. Center for Cognitive Liberty & Ethics. Retrieved on 2007-10-14.
- Siebert, Daniel (June 1994), "Salvia divinorum and salvinorin A: new pharmacologic findings", Journal of Ethnopharmacology 43(1): 53–56, doi:10.1016/0378-8741(94)90116-3, PMID 7526076, <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=7526076>. Retrieved on 4 May 2007
- Siebert, Daniel (2002). "A Prominent Salvia Divinorum Researcher Speaks Out: Letter to Congress (RE: Bill H.R. 5607)". The Entheogens and Drug Policy Project. Center for Cognitive Liberty & Ethics. Retrieved on 2007-10-16.
- Siebert, Daniel. "How to obtain effects from smoked Salvia divinorum". The Salvia divinorum Research and Information Center. Retrieved on 2007-06-19.
- Siebert, Daniel. "The Salvia divinorum FAQ". The Salvia divinorum Research and Information Center. Retrieved on 2007-07-05.
- Sage Student; Daniel Siebert. "The Salvia divinorum User’s Guide". The Salvia divinorum Research and Information Center. Retrieved on 2007-06-27.
- Siebert, Daniel. "Salvia Divinorum Inspired Arts". The Salvia divinorum Research and Information Center. Retrieved on 2007-06-28.
- Siebert, Daniel. "The Legal Status of Salvia divinorum". The Salvia divinorum Research and Information Center. Retrieved on 2007-03-04.
- Strain, Rep. Michael G. (2005). "Louisiana Law, Revised Statues, Rule Number 40, Section Number 989.1 — Unlawful production, manufacture, distribution, or possession of hallucinogenic plants". The Louisiana State Legislature. Retrieved on 2008-09-15.
- Teel. (Apr 2006) Assemblymen Jack Conners and Herb Conaway. Retrieved from PoliticsNJ.com on July 21, 2007.
- Tidgewell, Kevin; Harding, Wayne; Holden, Ken; Dersch, Christina; Butelman, Eduardo; Rothman, Richard & Prisinzano, Thomas (September 2004), "Neoclerodane Diterpenes as Potential Drug Abuse Therapeutics", The AAPS Journal 6(Theme issue:Drug Addiction—From Basic Research to Therapies (AAPS-NIDA Symposium Frontiers in Science)), <http://www.aapspharmsci.org/theme_issues/abstracts/view.asp?art=Front-04-00022&pdf=yes>. Retrieved on 20 May 2007
- Turner, D.M. (August 1996). "Effects and Experiences", Salvinorin—The Psychedelic Essence of Salvia Divinorum. San Francisco, CA: Panther Press. ISBN 0-9642636-2-9. Retrieved on 2007-05-20.
- Valdés, Leander J. III; Díaz, José Luis & Paul, Ara G. (May 1983), "Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M)", Journal of Ethnopharmacology 7(3): 287–312, doi:10.1016/0378-8741(83)90004-1, <http://www.salvia-divinorum-scotland.co.uk/salvia/ethnopharmacology.htm>. Retrieved on 4 May 2007
- Valdés, Leander J. III (2001). "The Early History of Salvia divinorum". The Entheogen Review X (1): 73–75. Retrieved on 2007-08-16.
- Wasson, R. Gordon (November 1963), "Notes on the Present Status of Ololiuhqui and the Other Hallucinogens of Mexico", Botanical Museum Leaflets, Harvard University 20(6): 161–212, <http://pages.prodigy.com/GBonline/liquix.htm>. Retrieved on 15 September 2007
- YouTube (2008). "YouTube Community Guidelines". YouTube. Retrieved on 2008-09-17.
- Zhang, Yong; Butelman, Eduardo R.; Schlussman, Stefan D.; Ho, Ann & Kreek, Mary Jeanne (May 2005), "Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at κ-Opioid receptors", Psychopharmacology 179(3): 551–558, doi:10.1007/s00213-004-2087-0, <http://www.springerlink.com/content/2e2e65wvctqbenvl/>. Retrieved on 4 May 2007
Further research
Source: http://en.wikipedia.org/wiki/Salvia_divinorum
- Epling, Carl & Játiva-M, Carlos D. (December 1962), "A New Species of Salvia from Mexico", Botanical Museum Leaflets, Harvard University 20(3), <http://www.sagewisdom.org/epling&jativa.html>. Retrieved on 8 May 2007
- Hanes, Karl R. (Spring 2003), "Salvia divinorum: Clinical and Research Potential", Multidisciplinary Association for Psychedelic Studies 13(1): 18–20, <http://www.maps.org/news-letters/v13n1/13118han.html>. Retrieved on 19 May 2007
- Hofmann, Albert (1980). "Chapter 6. The Mexican Relatives of LSD", LSD—My Problem Child. New York: McGraw-Hill. ISBN 0-07-029325-2.
- Sherratt, Dr Andrew (Presenter); Sarah Marris (Producer); with Daniel Seibert, Dr Françoise Barbira-Freedman, Dr Tim Kendell, Dr Jon Robbins and Sean Thomas. (1998). Sacred Weeds: Salvia divinorum (video) [Documentary]. UK: TVF Productions (for Channel 4). Retrieved on 2007-08-08.
- Wasson, R. Gordon (December 1962), "A New Mexican Psychotropic Drug from the Mint Family", Botanical Museum Leaflets, Harvard University 20(3): 53–56, <http://www.sagewisdom.org/wasson1.html>. Retrieved on 6 May 2007
Articles from Scientific Journals and Other Publications
All the resources cited below are to be found at:
http://www.sagewisdom.org
|
- Salvia divinorum and Salvinorin A: New Pharmacologic Findings.
by Daniel Siebert. Journal of Ethnopharmacology. 43: 53–56 (1994).
|
|
- Localization of Salvinorin A and Related Compounds in Glandular Trichomes of the Psychoactive Sage, Salvia divinorum.
by Daniel Siebert. Annals of Botany 93(6): 763–771 (2004).
|
|
- High Performance Liquid Chromatographic Quantification of Salvinorin A from Tissues of Salvia divinorum Epling & Játiva-M.
by Gruber JW, Siebert DJ, Der Marderosian AH, and Hock RS. Phytochemical Analysis 10(1):22–25 (1999).
|
|
- Salvinorin A: A Potent Naturally Occurring Nonnitrogenous Kappa Opioid Selective Agonist.
by Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, and Rothman RB.
PNAS. 99(18): 11934–11939 (2002).
Supporting information: table 3, table 4, table 5.
|
|
- Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum, is a Highly Efficacious
Kappa Opioid Receptor Agonist: Structural and Functional Considerations.
by Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, and Roth BL.
The Journal of Pharmacology and Experimental Therapeutics. 308(3): 1197–1203 (2004).
|
|
- Comparison of Pharmacological Activities of Three Distinct Kappa-Ligands (Salvinorin A, TRK-820 and 3FLB)
on opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
by Wang Y, Tang K, Inan S, Siebert DJ, Holzgrabe U, Lee DYW, Huang P, Li JG, Cowan A, and Liu-Chen LY.
The Journal of Pharmacology And Experimental Therapeutics. 312(1): 220–230 (2005).
|
|
- 2-Methoxymethyl-Salvinorin B is a Potent Kappa Opioid Receptor Agonist with Longer-Lasting Action In Vivo than Salvinorin A.
by Wang Y, Chen Y, Xu W, Lee DY, Ma Z, Rawls SM, Cowan A, Liu-Chen LY.
The Journal of Pharmacology And Experimental Therapeutics. [Epub ahead of print December 18, 2007].
|
|
- The Hallucinogenic Herb Salvia divinorum and Its Active Ingredient Salvinorin A Inhibit Enteric Cholinergic Transmission in the Guinea Pig Ileum.
by Capasso R, Borrelli F, Capasso F, Siebert DJ, Stewart DJ, Zjawiony JK, Izzo AA.
Neurogastroenterology and Motility. 18: 69–75 (2006).
|
|
- The Hallucinogenic Herb Salvia divinorum and Its Active Ingredient Salvinorin A Reduce Inflammation-Induced Hypermotility in Mice.
by Capasso R, Borrelli F, Zjawiony J, Kutrzeba L, Aviello G, Sarnelli G, Capasso F, Izzo AA.
Neurogastroenterology and Motility. [Epub ahead of print Sep 4, 2007].
|
|
- Antinociceptive and Hypothermic Effects of Salvinorin A are Abolished in a Novel Strain of KOR-1 KO Mice.
by Ansonoff MA, Zhang J, Czyzyk T, Rothman RB, Stewart J, Xu H, Zjwiony J, Siebert DJ, Yang F, Roth BL, Pintar JE.
The Journal of Pharmacology and Experimental Therapeutics. 318(2): 641-648 (2006).
|
|
- Daniel Siebert Speaks…
Interviewed by Will Beifuss. The Entheogen Review. Vol. 8 No. 3, Autumn 1999.
|
|
- The History of the First Salvia divinorum Plants Cultivated Outside of Mexico.
by Daniel Siebert. The Entheogen Review. Vol. 12 No. 4, Winter 2003.
|
|
- Salvinorin A: The ‘Magic Mint’ Hallucinogen Finds a Molecular Target in the Kappa Opioid Receptor.
by Sheffler DJ and Roth BL. Trends in Pharmacological Sciences. Vol.24 No.3 March 2003.
|
|
- Salvinorin A: A Novel and Highly Selective Kappa-Opioid Receptor Agonist.
by Yan F and Roth BL. Life Sciences. Vol.75 No.22 (2004).
|
|
- Salvinorin A: From Natural Product to Human Therapeutics.
by Vortherms TA and Roth BL. Molecular Interventions. Vol.6 No.5 (2006).
|
|
- Differential Helical Orientations Among Related G Protein-Coupled Receptors Provide a Novel Mechanism for Selectivity:
Studies with Salvinorin A and the Kappa-Opioid Receptor.
by Vortherms TA, Mosier PD, Westkaemper RB, Roth BL.
Journal of Biological Chemistry. 282(5): 3146–3156 (2007).
|
|
- Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A.
by Mowry M, Mosher M, Briner W. Journal of Psychoactive Drugs. 35(3): 379–382 (2003).
|
|
- The Plant-Derived Hallucinogen, Salvinorin A, Produces Kappa-Opioid Agonist-like Discriminative Effects in Rhesus Monkeys.
by Butelman E, Harris T, and Kreek MJ. Psychopharmacology (Berl). 172(2): 220–224 (2004).
|
|
- Effects of Salvinorin A, a Kappa-Opioid Hallucinogen, on a Neuroendocrine Biomarker Assay
in Nonhuman Primates With High Kappa-Receptor Homology to Humans.
by Butelman ER, Mandau M, Tidgewell K, Prisinzano TE, Yuferov V, Kreek MJ.
Journal of Pharmacology and Experimental Therapeutics. 320(1): 300–306 (2007).
|
|
- A New Species of Salvia from Mexico.
by Carl Epling and Carlos D. Játiva–M. Botanical Museum Leaflets Harvard University (1962).
|
|
- A New Mexican Psychotropic Drug From the Mint Family.
by R. Gordon Wasson. Botanical Museum Leaflets Harvard University (1962).
|
|
- Notes on the Present Status of Ololiuhqui and the Other Hallucinogens of Mexico.
by R. Gordon Wasson. Botanical Museum Leaflets Harvard University (1963).
|
|
- A Mazatec girl preparing Salvia divinorum leaves on a metate.
Photo taken in 1962 by R. Gordon Wasson.
|
|
- In Search of the Magic Plant "Ska Maria Pastora" in the Mazatec Country.
by Albert Hofmann. From: LSD: My Problem Child (1979).
|
|
- Salvinorin, A New trans-Neoclerodane Diterpene from Salvia divinorum (Labiatae).
by Ortega A, Blount JF, Manchand PS. Journal of the Chemical Society Perkins Transactions I (1982).
|
|
- Ethnopharmacology of Ska Maria Pastora (Salvia divinorum, Epling and Játiva-M.).
by L.J. Valdés J III, et al. Journal of Ethnopharmacology (1983).
|
|
- Etnofarmacologia di Ska Maria Pastora (Salvia divinorum, Epling and Játiva-M.) An Italian translation of the above.
|
|
- Divinorin A, a Psychotropic Terpenoid, and Divinorin B from the Hallucinogenic Mexican Mint, Salvia divinorum.
by L.J. Valdés III, et al. Journal of Organic Chemistry (1984).
|
|
- Loliolide from Salvia divinorum.
by L.J. Valdés III. Journal of Natural Products (1986).
|
|
- Studies of Salvia divinorum (Lamiaceae), an Hallucinogenic Mint from the Sierra Mazateca in Oaxaca, Central Mexico.
by L.J. Valdés III, et al. Economic Botany (1987).
|
|
- Salvia divinorum and the Unique Diterpene Hallucinogen, Salvinorin (Divinorin) A.
by L.J. Valdés III. Journal of Psychoactive Drugs (1994).
|
|
- "Divinorin C," a New Neoclerodane Diterpene from a Bioactive TLC Fraction of Salvia divinorum.
Lab notes from the desk of L. J. Valdés III. The Salvia divinorum Research and Information Center (2000).
|
|
- Salvinorin C, a New Neoclerodane Diterpene from a Bioactive Fraction of the Hallucinogenic Mexican Mint Salvia divinorum.
by L.J. Valdés III, et al. Organic Letters (2001).
|
|
- The Early History of Salvia divinorum.
by L. J. Valdés III. The Entheogen Review (2001) X(2): [73-75]
|
|
- Some photos of Salvia divinorum from the Sierra Mazateca. by L.J. Valdés III
|
|
- The Absolute Stereochemistry of Salvinorins.
by Koreeda, M., et al. Chemistry Letters (1990).
|
|
- Kappa-Opioid Receptor-Mediated Effects of the Plant-Derived Hallucinogen, Salvinorin A, on Inverted Screen Performance in the Mouse.
by Fantegrossi WE, Kugle KM, Valdιs LJ III, Koreeda M, Woods JH.
Behavioural pharmacology. 16(8): 627-633 (2005).
|
|
- Salvinorins D-F, New Neoclerodane Diterpenoids from Salvia divinorum, and an Improved Method for the Isolation of Salvinorin A.
And supporting information. by Munro TA, Rizzacasa MA.
Journal of Natural Products. 66(5): 703-705 (2003).
|
|
- Divinatorins A-C, New Neoclerodane Diterpenoids from the Controlled Sage Salvia divinorum. And supporting information.
by Bigham AK, Munro TA, Rizzacasa MA, Robins-Browne RM.
Journal of Natural Products. 66(9): 1242-1244 (2003).
|
|
- Studies Toward the Pharmacophore of Salvinorin A, a Potent Kappa Opioid Receptor Agonist.
And supporting information.by Munro T, Rizzacasa M, Roth BL, Toth B, Yan F
Journal of Medicinal Chemistry. 48(2): 345–348 (2005).
|
|
- Autoxidation of Salvinorin A under Basic Conditions.
And supporting information.by Munro T, Goetchius G, Roth BL, Vortherms T, Rizzacasa M.
Journal of Organic Chemistry. 70(24): 10057-10061 (2005).
|
|
- 8-epi-Salvinorin B: Crystal Structure and Affinity at the Kappa Opioid Receptor.
by Munro TA, Duncan KK, Staples RJ, Xu W, Liu-Chen LY, Beguin C, Carlezon WA Jr, Cohen BM.
Beilstein Journal of Organic Chemistry. Epub ahead of print (2007).
|
|
- The Chemistry of Salvia divinorum.
by Thomas Munro. PhD dissertation.
|
|
- Standard Protecting Groups Create Potent and Selective Kappa Opioids: Salvinorin B Alkoxymethyl Ethers
by Munro TA, Duncan KK, Xu W, Wang Y, Liu-Chen LY, Carlezon WA Jr, Cohen BM, Beguin C.
Bioorganic and Medicinal Chemistry. [Epub ahead of print October 24, 2007].
|
|
- Antidepressant Effects of the Herb Salvia divinorum: a Case Report.
by Karl R. Hanes, PhD. Journal of Clinical Psychopharmacology (2001).
|
|
- Salvia divinorum: Clinical and Research Potential.
by Hanes KR. MAPS Bulletin 13(1): 18–20 (2003).
|
|
- Salvia divinorum and Salvinorin A: An Update on Pharmacology and Analytical Methodology.
by Grundmann O, Phipps SM, Zadezensky I, Butterweck V.
Planta Medica 73(10): 1039–1046 (2007).
|
|
- Use of Nonprohibited Hallucinogenic Plants: Increasing Relevance for Public Health?
A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).
by Bόcheler R, Gleiter CH, Schwoerer P, and Gaertner I.
Pharmacopsychiatry. 38(1): 1–5 (2005).
|
|
- A Facile Method for the Preparation of Deuterium Labeled Salvinorin A: Synthesis of [2,2,2-2H3]-Salvinorin A
by Kevin Tidgewell, Wayne W. Harding, Mark Schmidt, Kenneth G. Holden, Daryl J. Murry, and Thomas E. Prisinzano.
Bioorganic and Medicinal Chemistry Letters. 14(20): 5099-5102 (2004).
|
|
- Salvinicins A and B, New Neoclerodane Diterpenes from Salvia divinorum.
by Harding WW, Tidgewell K, Schmidt M, Shah K, Dersch CM, Snyder J, Parrish D, Deschamps JR, Rothman RB, Prisinzano TE.
Organic Letters. 7(14): 3017–3020 (2005).
|
|
- Neoclerodane Diterpenes as a Novel Scaffold for Mu Opioid Receptor Ligands.
by Harding WW, Tidgewell K, Byrd N, Cobb H, Dersch CM, Butelman ER, Rothman RB, Prisinzano TE.
Journal of Medicinal Chemistry. 48(15): 4765–4771 (2005).
|
|
- An Opioid Agonist That Does Not Induce Mu-Opioid Receptor–Arrestin Interactions or Receptor Internalization.
by Groer CE, Tidgewell K, Moyer RA, Harding WW, Rothman RB, Prisinzano TE, Bohn LM.
Molecular Pharmacology. 71(2): 549–557 (2007).
|
|
- Salvinorin A: Allosteric Interactions at the Mu-Opioid Receptor.
by Rothman RB, Murphy DL, Xu H, Godin JA, Dersch CM, Partilla JS, Tidgewell K, Schmidt M, Prisinzano TE.
Journal of Pharmacology and Experimental Therapeutics. 320(2): 801–810 (2007).
|
|
- Determination of Salvinorin A in Body Fluids by High Performance Liquid Chromatography-Atmospheric Pressure Chemical Ionization.
by Schmidt MS, Prisinzano TE, Tidgewell K, Harding W, Butelman ER, Kreek MJ, and Murry DJ.
Journal of Chromatography. B. 818(2): 221–225 (2005).
|
|
- Pharmacokinetics of the Plant-Derived Kappa-Opioid Hallucinogen Salvinorin A in Nonhuman Primates.
by Schmidt MD, Schmidt MS, Butelman ER, Harding WW, Tidgewell K, Murry DJ, Kreek MJ, Prisinzano TE.
Synapse. 58(3): 208–210 (2005).
|
|
- Psychopharmacology of the Hallucinogenic Sage Salvia divinorum.
by Prisinzano TE.
Life Sciences. 78(5): 527-531 (2005).
|
|
- Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Semisynthesis of Salvinicins A and B
and Other Chemical Transformations of Salvinorin A.
by Harding WW, Schmidt M, Tidgewell K, Kannan P, Holden KG, Gilmour B, Navarro H, Rothman RB, Prisinzano TE.
Journal of Natural Products. 69(1): 107–112 (2006).
|
|
- Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Selective Modification of the Furan Ring.
by Harding WW, Schmidt M, Tidgewell K, Kannan P, Holden KG, Dersch CM, Rothman RB, Prisinzano TE.
Bioorganic & Medicinal Chemistry Letters. 16(12): 3170–3174.
|
|
- Synthesis of Salvinorin A Analogues as Opioid Receptor Probes.
by Tidgewell K, Harding WW, Lozama A, Cobb H, Shah K, Kannan P, Dersch CM, Parrish D, Deschamps JR, Rothman RB, Prisinzano TE.
Journal of Natural Products. 69(6): 914–918 (2006).
|
|
- Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Preparation and Opioid Receptor Activity of Salvinicin Analogues.
by Simpson DS, Katavic PL, Lozama A, Harding WW, Parrish D, Deschamps JR, Dersch CM, Partilla JS, Rothman RB, Navarro H, Prisinzano TE.
Journal of Medicinal Chemistry. [ePublished ahead of print Jun 20, 2007].
|
|
- Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Exploration of the 1-Position.
by Holden KG, Tidgewell K, Marquam A, Rothman RB, Navarro H, Prisinzano TE.
Bioorganic and Medicinal Chemistry Letters. . 17(22): 6111–6115 (2008).
|
|
- Neo-clerodane Diterpenes from the Hallucinogenic Sage Salvia divinorum.
And errata. by Shirota O, Nagamatsu K, Sekita S.
Journal of Natural Products. 69(12): 1782–1786. (2006).
|
|
- Asymmetric Synthesis of Salvinorin A, a Potent Kaapa Opioid Receptor Agonist.
by Scheerer JR, Lawrence JF, Wang GC, Evans DA.
Supporting information here (4 MB file).
Journal of the American Chemical Society. [ePublished ahead of print June 30, 2007].
|
|
- Total Synthesis of the Hallucinogenic Neoclerodane Diterpenoid Salvinorin A.
by Nozawa M, Suka Y, Hoshi T, Suzuki T, Hagiwara H.
Organic Letters. [ePublished ahead of print March 1, 2008].
|
|
- Quantification of the Plant-Derived Hallucinogen Salvinorin A in Conventional and Non-Conventional Biological Fluids
by gas chromatography/mass spectrometry after Salvia divinorum smoking.
by Pichini S, Abanades S, Farre M, Pellegrini M, Marchei E, Pacifici R, Torre RD, and Zuccaro P.
Rapid Communications in Mass Spectrometry. 19(12): 1649–1656 (2005).
|
|
- Synthesis and In Vitro Pharmacological Evaluation of Salvinorin A Analogues Modified at C(2).
by Beguin C, Richards MR, Wang Y, Chen Y, Liu-Chen LY, Ma Z, Lee DY, Carlezon WA Jr, and Cohen BM.
Bioorganic and Medicinal Chemistry Letters. 15(11): 2761–2765 (2005).
|
|
- Synthesis and In Vitro Pharmacological Studies of New C(2) Modified Salvinorin A Analogues.
by Lee DY, Karnati VV, He M, Liu-Chen LY, Kondareti L, Ma Z, Wang Y, Chen Y, Beguin C, Carlezon WA Jr, Cohen B.
Bioorganic and Medicinal Chemistry Letters. 15(16): 3744–3747 (2005).
|
|
- Synthesis and In Vitro Pharmacological Studies of C(4) Modified Salvinorin A Analogues.
by Lee DY, He M, Kondaveti L, Liu-Chen LY, Ma Z, Wang Y, Chen Y, Li JG, Beguin C, Carlezon WA Jr, Cohen B.
Bioorganic and Medicinal Chemistry Letters. Jul 25, 2005 [Epub ahead of print].
|
|
- New Neoclerodane Diterpenoids Isolated From the Leaves of Salvia divinorum and Their Binding Affinities for Human Kappa Opioid Receptors.
by Lee DY, Ma Z, Liu-Chen LY, Wang Y, Chen Y, Carlezon WA Jr, Cohen B.
Bioorganic and Medicinal Chemistry Letters. Aug 3, 2005 [Epub ahead of print].
|
|
- Synthesis and In Vitro Pharmacological Studies of New C(4)-Modified Salvinorin A Analogues.
by Lee DY, He M, Liu-Chen LY, Wang Y, Li JG, Xu W, Ma Z, Carlezon WA Jr, Cohen B
Bioorganic and Medicinal Chemistry Letters. 16(21): 5498–5502 (2006).
|
|
- Depressive-like Effects of the Kappa-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats.
by Carlezon Jr WA, Beguin C, Dinieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM.
Journal of Pharmacology and Experimental Therapeutics. 316(1): 440–447 (2006).
|
|
- Synthesis and In Vitro Evaluation of Salvinorin A Analogues: Effect of Configuration at C(2) and Substitution at C(18).
by Beguin C, Richards MR, Li JG, Wang Y, Xu W, Liu-Chen LY, Carlezon WA Jr, Cohen BM.
Bioorganic and Medicinal Chemistry Letters. 16(17): 4679–4685 (2006).
|
|
- Revised Structure of Deacetyl-1,10-didehydrosalvinorin G.
by Ma Z, Lee DY.
Tetrahedron Letters. 48(31): 5461–5464 (2007).
|
|
- N-Methylacetamide Analogue of Salvinorin A: A Highly Potent and Selective Kappa Opioid Receptor Agonist with Oral Efficacy.
by Beguin C, Potter DN, Dinieri JA, Munro TA, Richards MR, Paine TA, Berry L, Zhao Z, Roth BL, Xu W, Liu-Chen LY, Carlezon Jr WA, Cohen BM.
The Journal of Pharmacology and Experimental Therapeutics. 324(1): 188–195 (2008).
|
|
- Exposure to the Selective Kappa-Opioid Receptor Agonist Salvinorin A Modulates the Behavioral and Molecular Effects of Cocaine in Rats.
by Chartoff EH, Potter D, Damez-Werno D, Cohen BM, Carlezon WA Jr
Neuropsychopharmacology. [Epub ahead of print Jan 9, 2008].
|
|
- Identification of the Molecular Mechanisms by Which the Diterpenoid Salvinorin A Binds to Kappa-Opioid Receptors.
by Yan F, Mosier PD, Westkaemper RB, Stewart J, Zjawiony JK, Vortherms TA, Sheffler DJ, Roth BL.
Biochemistry. 44(24): 8643–8651 (2005).
|
|
- Unambiguous NMR Spectral Assignments of Salvinorin A.
by Giner JL, Kiemle DJ, Kutrzeba L, Zjawiony J.
Magnetic Resonance in Chemistry. 45(4): 351–354 (2007).
|
|
- Biosynthesis of Salvinorin A Proceeds via The Deoxyxylulose Phosphate Pathway.
by Kutrzeba L, Dayan FE, Howell J, Feng J, Giner JL, Zjawiony JK.
Phytochemistry. 68(14): 1872–1881 (2007).
|
|
- Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.
by Bikbulatov RV, Yan F, Roth BL, Zjawiony JK.
Bioorganic and Medicinal Chemistry Letters. 17(8): 2229–2232 (2007).
|
|
- Short Synthesis of a Novel Class of Salvinorin A Analogs with Hemiacetalic Structure.
by Bikbulatov RV, Stewart J, Jin W, Yan F, Roth BL, Ferreira D, Zjawiony JK.
Tetrahedron Letters. 49: 937–940 (2008).
|
|
- Studies Towards the Synthesis of Salvinorin A.
by Lingham AR, Hόgel HM, Rook TJ.
Australian Journal of Chemistry. 59(5): 340–348 (2006).
|
|
- Determination of Salvinorins and Divinatorins in Salvia divinorum Leaves by Liquid Chromatography/Multistage Mass Spectrometry.
by Medana C, Massolino C, Pazzi M, Baiocchi C.
Rapid Communications in Mass Spectrometry. 20(2): 131–136 (2005).
|
|
- Analysis of the Psychoactive Terpenoid Salvinorin A Content in Five Salvia divinorum Herbal Products..
by Wolowich WR, Perkins AM, Cienki JJ.
Pharmacotherapy. 26(9): 1268–1272(2006).
|
|
- The Antinociceptive Effect of Salvinorin A in Mice.
by Trentini, John F., Larry G. French, and Joseph S. Erlichman.
European Journal of Pharmacology. 545 (2–3): 129–133 (2006).
|
|
- Antinociceptive Profile of Salvinorin A, a Structurally Unique Kappa Opioid Receptor Agonist.
by McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ.
Pharmacology, Biochemistry, and Behavior. [Epub ahead of print Jan 20, 2006].
|
|
- A Unique Binding Epitope for Salvinorin A, a Non-Nitrogenous Kappa Opioid Receptor Agonist.
by Kane BE, Nieto MJ, McCurdy CR, Ferguson DM.
FEBS Journal. 273(9): 1966–1974 (2006).
|
|
- Toward a Structure-Based Model of Salvinorin A Recognition of the Kappa-Opioid Receptor.
by Kane BE, McCurdy CR, Ferguson DM.
Journal of Medicinal Chemestry. [ePublished ahead of print Feb 23, 2008].
|
|
- A Combined Ligand-Based and Target-Based Drug Design Approach for G-Protein Coupled Receptors:
Application to Salvinorin A, a Selective Kappa Opioid Receptor Agonist.
by Singh N, Chevé G, Ferguson DM, McCurdy CR.
Journal of Computer-Aided Molecular Design. 20(7–8): 471–493 (2006).
|
|
- The Hallucinogen Derived from Salvia divinorum, Salvinorin A, has κ-Opioid Agonist Discriminative Stimulus Effects in Rats.
by Willmore-Fordham CB, Krall DM, McCurdy CR, Kinder DH.
Neuropharmacology. 53(4): 481–486 (2007).
|
|
- Discriminative Stimulus Effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in Rhesus Monkeys.
by Li JX, Rice KC, France CP.
Journal of Pharmacology and Experimental Therapeutics. [Epub ahead of print Novevember 9, 2007].
|
|
- Intramolecular Diels-Alder/Tsuji Allylation Assembly of the Functionalized Trans-Decalin of Salvinorin A.
by Burns AC, Forsyth CJ.
Organic Letters. 10(1): 97–100 (2008).
|
|
- PCR and PCR-RFLP of the 5S-rRNA-NTS Region and Salvinorin A Analyses for the Rapid and Unequivocal Determination of Salvia divinorum.
by Bertea CM, Luciano P, Bossi S, Leoni F, Baiocchi C, Medana C, Azzolin CM, Temporale G, Lombardozzi MA, Maffei ME.
Phytochemistry. 67(4): 371–378 (2006).
|
|
- Authentication and Ultra Performance Liquid Chromatography (UPLC)/MS Analysis of Magic Mint, Salvia divinorum and Its Related Plants.
by Maruyama T, Kamakura H, Kikura-Hanajiri R, Goda Y.
Yakugaku Zasshi. 128(1): 179–183 (2008).
|
|
- Hallucinatory and Rewarding Effect of Salvinorin A in Zebrafish: Kappa-Opioid and CB1-Cannabinoid Receptor Involvement.
by Braida D, Limonta V, Pegorini S, Zani A, Guerini-Rocco C, Gori E, Sala M.
Psychopharmacology. 190(4): 441–448 (2007).
|
|
- Involvement of Kappa-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward.
by Braida D, Limonta V, Capurro V, Fadda P, Rubino T, Mascia P, Zani A, Gori E, Fratta W, Parolaro D, Sala M.
Biological Psychiatry. 63(3): 286–292 (2008).
|
|
- Opioid Receptors and Legal Highs: Salvia divinorum and Kratom.
by Babu KM, McCurdy CR, Boyer EW.
Clinical Toxicology (Philadelphia, PA). 46(2): 146–152 (2008).
|
|
- Ethnopharmacognosy and Human Pharmacology of Salvia divinorum and Salvinorin A.
by Jonathan Ott. Curare. 18(1): 103-129 (1995).
|
|
- Psychoactive Card IV. Salvia divinorum Epling et Játiva: Leaves of the Shepherdess.
by Jonathan Ott. Eleusis, n. 4, pp. 31-39, 1996.
|
|
- Scheda Psicoattiva IV. Salvia divinorum Epling et Játiva: Foglie della Pastora An Italian translation of the above.
|
|
- Dose-Response Effects of Salvinorin A on Basal Dopamine Levels in the Caudate Putamen of C57BL/6J Mice.
by Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ.
|
|
- Effects of the Plant-Derived Hallucinogen Salvinorin A on Basal Dopamine Levels in the Caudate Putamen
and in a Conditioned Place Aversion Assay in Mice: Agonist Actions at Kappa Opioid Receptors.
by Yong Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ.
Psychopharmacology (Berl). 179(3): 551–558 (2005).
|
|
- Pharmacokinetics of the Potent Hallucinogen, Salvinorin A in Primates Parallels the Rapid Onset and Short Duration of Effects in Humans.
by Hooker JM, Xu Y, Schiffer W, Shea C, Carter P, Fowler JS.
Neuroimage. ePublished ahead of print March 15, 2008.
|
|
- Effects of Acute and Repeated Administration of Salvinorin A on Dopamine Function in the Rat Dorsal Striatum.
by Gehrke BJ, Chefer VI, Shippenberg TS.
Psychopharmacology (Berl). [ePublished ahead of print Feb 2, 2008].
|
|
- A Select Set of Opioid Ligands Induce Up-Regulation by Promoting the Maturation
and Stability of the Rat Kappa Opioid Receptor in Human Embryonic Kidney 293 Cells.
by Wannemacher KM, Yadav PN, Howells RD.
Journal of Pharmacology and Experimental Therapies. [Epub ahead of print Aug 24, 2007].
|
|
- Pharmacological Characterization of the Novel Kappa Opioid Agonist Salvinorin A in the Mouse
This study demonstrates that salvinorin A is active in vivo at kappa opioid receptors.
|
|
- The Rise of a New Psychoactive Agent: Salvia divinorum.
by Appel J, Kim-Appel D.
International Journal of Mental Health and Addiction. 5: 248–253 (2007).
|
|
- Use of Salvia divinorum, an Unscheduled Hallucinogenic Plant: A Web-Based Survey of 500 Users.
This survey characterized the reasons, methods, and reported consequences of Salvia divinorum use.
|
|
- Pattern of Use and Subjective Effects of Salvia divinorum Among Recreational Users.
by González D, Riba J, Bouso JC, Gómez-Jarabo G, Barbanoj MJ.
Drug and Alcohol Dependence. 85(2): 157–162 (2006).
|
|
- Salvia divinorum–Prësenz einer neuen Droge im Internet. [Salvia divinorum—Representation of a New Drug in the Internet.]
[Abstract in English and German. Article in German only].
by Siemann H, Specka M, Schifano F, Deluca P, Scherbaum N.
Gesundheitswesen. 68(5): 323–327 (2006).
|
|
- Internet Access to Salvia divinorum: Implications for Policy, Prevention, and Treatment.
by Hoover V, Marlowe DB, Patapis NS, Festinger DS, Forman RF.
Journal of Substance Abuse Treatment. [Epub ahead of print Oct 9, 2007].
|
|
- College student use of Salvia divinorum.
by Lange JE, Reed MB, Croff JM, Clapp JD.
Drug and Alcohol Dependence. [Epub ahead of print Dec 17, 2007].
|
|
- Salvia divinorum Epling et Játiva-M. (Labiatae): An Ethnopharmacological Investigation.
by Sherry A. Rovinsky. McNair Scholarly Review (1998).
|
|
- Salvia divinorum: An Hallucinogenic Mint Which Might Become a New Recreational Drug in Switzerland.
Giroud et al. Forensic Science International. 112(2–3): 143–150 (2000).
|
|
- Salvinorin: The Psychedelic Essence of Salvia divinorum. An extraordinary book by D.M.Turner (1996).
|
|
- The Mushrooms of Language by Henry Munn. This essay provides valuable insight into the Mazatec shamanic world.
|
|
- NovaScreen® receptor selectivity report on salvinorin-A.
|
|
- Sage Wisdom: Salvia divinorum Branches Out. by Robert Campbell. An article from TRP Magazine (1997).
|
|
- Cultivating Diviner's Sage by Will Beifuss. An article from TRP Magazine (1997).
|
|
- Under the Spell of the Magic Mint. by Christopher Ketcham. Published in GQ magazine. June, 2007.
|
|
|